Optimally preserved human tissue specimens are the backbone of cancer research for basic, clinical, translational and population scientists. The purpose of the Tissue Core (TC) is: 1. To ensure the collection and storage of well-annotated human tissues for research, and to provide investigators with access to high quality human specimens, including fresh and frozen tissues, fixed tissue, and DNA/RNA products. 2. To provide histology, immunohistochemistry and in-situ hybridization services for paraffin embedded tissue. These services, outsourced in the prior core submission, have been incorporated within the Moffitt Tissue Core Facility. 3. To manufacture tissue microarrays using our rich resource of archival material here at Moffitt Cancer Center. We have recently implemented a procedure for the transfer of all archival material no longer required for clinical care to the Tissue Core for research. These will provide a repository for the construction of tissue microarrays, a service that was also outsourced prior to this submission. The Core is administrated by Domenico Coppola, MD, and Mary E. Edgerton, MD, PhD, Scientific Directors, Tyron Hoover, MD, JD, Medical Director, and the Tissue Core Executive Committee (TCEC), a multidisciplinary committee responsible for recommending policy governing tissue release and utilization, and ensuring compliance with all appropriate regulatory bodies. On average, the Tissue Core has distributed over 1,000 tissue samples and nearly 800 nucleic acid derivatives per year to investigators. The Tissue Core (TC) future goals include implementation of standard tissue banking processes in a network of community hospitals, linking clinical outcomes to patient samples. In conjunction with the Informatics Core, TC is expanding its informatics support. There is also an ongoing effort to improve the collection, processing and storage of tissues, and to optimize the collection, processing and storage of fine needle aspirate specimens for molecular and proteomic analyses. Finally, TC is developing specialized tissue based molecular testing (FISH,C-ISH, gene polymorphism-Invader) as an adjunct to immunohistochemistry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-13
Application #
8214138
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-02-01
Budget End
2012-01-31
Support Year
13
Fiscal Year
2011
Total Cost
$168,581
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Phadke, Manali; Remsing Rix, Lily L; Smalley, Inna et al. (2018) Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition. Mol Oncol 12:74-88
Kasting, Monica L; Christy, Shannon M; Sutton, Steven K et al. (2018) Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med 116:143-149
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2018) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol 26:552-556
Park, Jae H; Rivière, Isabelle; Gonen, Mithat et al. (2018) Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med 378:449-459
Poort, Hanneke; Meade, Cathy D; Knoop, Hans et al. (2018) Adapting an Evidence-Based Intervention to Address Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia Patients. Cancer Nurs 41:E28-E37
Pamnani, Shitaldas J; Sudenga, Staci L; Rollison, Dana E et al. (2018) Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study. J Infect Dis 218:1219-1227
Dai, Juncheng; Li, Zhihua; Amos, Christopher I et al. (2018) Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis :
Cherezov, Dmitry; Hawkins, Samuel H; Goldgof, Dmitry B et al. (2018) Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial. Cancer Med 7:6340-6356

Showing the most recent 10 out of 1254 publications